Clinical Laserthermia Systems AB (CLSB)

📍 Sweden👥 20 employees💰 Last funded Jun 2020
Medical Equipment Manufacturing🌐 clinicallaser.se
Website LinkedIn
Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current approvals to also include treatment with imILT®, the Companys interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal treatment effect. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Clinical Laserthermia Systems AB (CLSB)?
Clinical Laserthermia Systems AB (CLSB) has 2 investors on record on gritt.io.
When did Clinical Laserthermia Systems AB (CLSB) last raise funding?
The most recent investment in Clinical Laserthermia Systems AB (CLSB) recorded on gritt.io was in June 2020.
What industry is Clinical Laserthermia Systems AB (CLSB) in?
Clinical Laserthermia Systems AB (CLSB) operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Clinical Laserthermia Systems AB (CLSB) based?
Clinical Laserthermia Systems AB (CLSB) is headquartered in Sweden.